Ribociclib

Back to search

Molecule Structure

Scientific Name

Ribociclib

Description of the Drug

Ribociclib is a kinase inhibitor used to treat HR+, HER2- advanced or metastatic breast cancer.

Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB11730

Brand Name(s)

Not Available

Company Owner(s)

Novartis Pharmaceuticals Corp

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Cyclin-dependent kinase 4 SINGLE PROTEIN INHIBITOR CHEMBL331
Cyclin-dependent kinase 6 SINGLE PROTEIN INHIBITOR CHEMBL2508

Unichem Links

SureChEMBL SCHEMBL302310
PharmGKB PA166153470
Human Metabolome Database HMDB0257211
DrugBank DB11730
PubChem: Thomson Pharma 87793394
PubChem 44631912
LINCS LSM-45221
Nikkaji J3.462.341D
PDBe 6ZZ
BindingDB 148264
DrugCentral 5218
ChemicalBook CB32677045
Guide to Pharmacology 7383
rxnorm RIBOCICLIB RIBOCICLIB SUCCINATE KISQALI
ZINC ZINC000072316335